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Chapter 1
Reviving the vascular surgeon–scientist: An
interim assessment of the jointly sponsored
Lifeline Foundation/National Heart, Lung, and
Blood Institute William J. von Liebig Mentored
Clinical Scientist Development (K08) Program
Robert W. Thompson, MD,a Beth Schucker, MS,b K. Craig Kent, MD,c Alexander W. Clowes, MD,d
Larry W. Kraiss, MD,e John A. Mannick, MD,f and James S. T. Yao, MD,g St. Louis, Mo, Bethesda, Md;
New York, NY; Seattle, Wash; Salt Lake City, Utah; Boston, Mass; and Chicago, Ill
The Lifeline Foundation/National Heart, Lung, and Blood Institute William J. von Liebig Mentored Clinical Scientist
Development (K08) Award program was established as a unique partnership to support vascular surgeon–scientists.
Between 1999 and 2005, 39 applications were submitted, and the overall funding rate was 49% (14 von Liebig K08s and
5 additional NHLBI K08s). Vascular surgeon K08 recipients (median age, 38 years) had held faculty appointments for
2.5  0.4 years, with 2.6  0.2 years of previous research experience and 28.4  6.2 publications. These individuals
subsequently authored 5.1  0.8 peer-reviewed publications per recipient per year, of which 35% were research and 65%
were clinical. Six of seven holding the K08 over 3 years had received academic promotion, and all five completing the
5-year award had achieved independent investigator status with National Institutes of Health support. The von Liebig
K08 program has therefore been an effective vehicle to stimulate research career development in the field of vascular
surgery. (J Vasc Surg 2007;45:2A-7A.)During the past decade, leaders in the field of vascular
surgery have expressed concerns about the viability of re-
search conducted by vascular surgeons, citing diminished
federal funding for vascular surgery research, declining
involvement of vascular surgeons in laboratory-based inves-
tigations, and diminished academic productivity.1-6 Similar
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2Aconcerns have been raised by others in the surgical commu-
nity on the fate of the surgeon–scientist,7-11 and physician–
scientists have warned of more general trends indicating a
broad decline in laboratory research conducted by clinically
trained individuals.12-18 Despite efforts to alter these
trends, academic medical centers have simultaneously faced
increasing financial challenges in supporting research career
development for clinically trained individuals, and the com-
petition for extramural research funding has continued to
grow more rigorous.19-23
In the early 1970s, the National Institutes of Health
(NIH) developed the Mentored Clinical Scientist Develop-
ment (K08) Award to help support career development in
laboratory-based basic and translational research for clini-
cally trained individuals. A similar award mechanism devel-
oped for training in patient-oriented research (K23) was
implemented in 1999. The K08/K23 awards are designed
to provide salary support and research project funds for a
period of 3 to 5 years.
During this time, the recipient is engaged in a struc-
tured research career development program that includes
both advanced didactic training and direct laboratory re-
search experience under the mentorship of a senior scien-
tist. To ensure adequate time to pursue this goal, it is
required that a minimum commitment of 75% of total
professional effort be applied to the research career devel-
opment program. For many clinical specialties, the salary
n Lie
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deficit created by the required 75% effort, thereby leaving a
substantial funding gap to support research career develop-
ment.
A new approach to supplement the K08 award in the
field of vascular surgery was developed in 1999 by the
Lifeline Foundation of the Society for Vascular Surgery
(now the American Vascular Association [AVA]) and the
National Heart, Lung, and Blood Institute (NHLBI),
which resulted in the establishment of the William J. von
Liebig K08 award program. This report evaluates the re-
sults and impact of the von Liebig K08 program during the
first 6 years of its implementation.
METHODS
The von Liebig K08 program was designated for indi-
viduals holding a faculty appointment in vascular surgery
and meeting the review and funding criteria for NHLBI
K08 awards, based on applications submitted simulta-
neously to both NHLBI and the Lifeline Foundation in
June of each year. Initial peer review and priority scoring
was conducted by the special emphasis panel responsible for
all NHLBI K-series applications, followed by secondary
review and funding decisions by the NHLBI Advisory
Council. Applicants successfully awarded NHLBI K08
funding were then reviewed by the Lifeline Foundation
Research and Education Committee, and up to two indi-
viduals each year were selected to receive the supplemental
salary support of the von Liebig K08 award. This additional
salary stipend was designated in the amount necessary to
achieve twice the annual total of salary support otherwise
provided by the NHLBI K08 award.
The funding outcomes for all applications submitted to
the von Liebig K08 program from 1999 to 2005 were
tabulated from a review of AVA and NHLBI records, and
overall funding rates for K08 awards were obtained from
the NHLBI. The characteristics of successfully funded vas-
cular surgeon K08 applicants and assessment of their re-
search productivity were based on personal communication
and review of individual curricula vitae that they provided.
Table I. Funding outcomes for vascular surgeon K08 awa
Year of award Applicants, n Awards funded von Liebig K
1999 6 2 (33)
2000 7 2 (29)
2001 6 2 (33)
2002 6 2 (33)
2003 4 2 (50)
2004 7 2 (29)
2005 3 2 (66)
Totals 39 14/39 (36)
NHLBI, National Heart, Lung, and Blood Institute.
The number of vascular surgeons submitting applications for the von Liebig
the number and percentage of applications funded (the number of applicant
awards refers to K08 applications submitted by vascular surgeons for the vo
Award supplement.Peer-reviewed publications before and after the year of theK08 award were obtained by a search of the National
Library of Medicine PubMed database, and original scien-
tific publications were classified as being related to labora-
tory research or to clinical topics. Descriptive statistics were
used to summarize the characteristics of the vascular sur-
geon K08 recipient cohort (means are presented  the
standard error).
RESULTS
Funding rates. Between 1999 and 2005, 39 applica-
tions were submitted to the von Liebig K08 program
(annual median, 6; range, 3 to 7). Of these, 14 applicants
(36%) received the von Liebig K08 award, and five addi-
tional applicants (13%) received NHLBI K08 awards (all
for 5 years’ duration), for an overall funding rate of 49%
(median annual funding rate, 50%; Table I). During the
same time period, the aggregate funding rate for all K08
applications submitted to NHLBI was 41% (annual range,
32% to 47%).
Characteristics of award recipients. Vascular sur-
geon K08 recipients included 16 with an MD degree (84%)
and three with a combined MD/PhD degree (16%; Table II).
All had completed a general surgical residency (median
duration, 5.0 years; range, 5 to 7 years; mean, 5.2  0.1
years) and a vascular surgery fellowship (median duration,
1.0 years; range, 1 to 2 years; mean, 1.2  0.1 years). The
median duration of faculty appointment (all at assistant
professor level) was 2.0 years (range, 0 to 7 years; mean,
2.5 0.4 years), and the median age at the time of the K08
application was 38.0 years (range, 34 to 42 years; mean,
37.6 0.5 years). All vascular surgeon K08 recipients were
engaged in an academic vascular surgery practice, with
direct patient care responsibilities encompassing no more
than 25% of total professional effort.
The median amount of previous research training for
vascular surgeon K08 recipients was 2.5 years (range, 1 to 5
years; mean, 2.6  0.2 years). Eighteen recipients (95%)
had performed laboratory-based research during general
surgery residency (median duration, 2.0 years; range, 0 to 4
years; mean, 1.9 0.2 years) and 13 (68%) during vascular
plicants, 1999 to 2005
(%) Other NHLBI K08 awards, n (%) Total K08, n (%)
1 (20) 3/6 (50)
0 (0) 2/7 (29)
0 (0) 2/6 (33)
2 (33) 4/6 (50)
0 (0) 2/4 (50)
2 (29) 4/7 (57)
0 (0) 2/3 (66)
5/39 (13) 19/39 (49)
award program is listed for each year from 1999 through 2005, along with
s to those submitted during the previous calendar year). Other NHLBI K08
big K08 program that received funding by NHLBI but not the von Liebigrd ap
08, n
K08
s refersurgery fellowship (median duration, 1.0 years; range, 0 to
JOURNAL OF VASCULAR SURGERY
June Supplement 20074A Thompson et al1 years; mean, 0.7  0.1 years). Twelve individuals (63%)
had performed research during both residency and fellow-
ship. Six of the recipients (32%) had received previous NIH
support through an individual (F32) or institutional (T32)
National Research Service Award (NRSA) during the time
of their research training, three (16%) had held an award
from the American Heart Association, and two (11%) had
obtained scholarship funding through a nonprofit surgical
foundation or academic society. The median number of
peer-reviewed publications per recipient before the year of
K08 application was 21.0 (range, 9 to 116; mean, 28.4 
6.2), including 10.0 research papers (range, 2 to 95; mean,
15.2  4.7) and 8.0 clinical papers (range, 2 to 61; mean,
13.2  3.2).
Vascular surgeon K08 recipients tended to be affiliated
with academic institutions characterized by a well-developed
research infrastructure, and all had been provided with
Table II. Characteristics of vascular surgeon K08
recipients, 1999 to 2005
N  19 (%)
Median
(range) Mean
Age at application (years) 38.0 (34-42) 37.6  0.5
Years in faculty
appointment 2.0 (0-7) 2.5  0.4
Degree
MD 16 (84.2)
MD/PhD 3 (15.8)
Previous clinical training
(years)
Clinical residency 5.0 (5-7) 5.2  0.1
Clinical fellowship 1.0 (1-2) 1.2  0.1
Total clinical training 6.0 (6-8) 6.3  0.1
Previous research
training
Research during
residency 18 (94.7)
Duration (years) 2.0 (0-4) 1.9  0.2
Research during
fellowship 13 (68.4)
Duration (years) 1.0 (0-1) 0.7  0.1
Research during both 12 (63.2)
Total research (years) 2.5 (1-5) 2.6  0.2
Previous peer-reviewed
publications
Laboratory research 10.0 (2-95) 15.2  4.7
Clinical
research/topics 8.0 (2-61) 13.2  3.2
Total publications 21.0 (9-116) 28.4  6.2
Previous research
funding
As a trainee
All sources 9 (47.4)
NHLBI F32 or T32 6 (31.6)
American Heart
Association 3 (15.8)
Surgical
foundation/society 2 (10.5)
As a faculty member
All sources 9 (47.4)
NHLBI, National Heart, Lung, and Blood Institute.appropriate time, laboratory space, and start-up researchfunding as part of their initial faculty appointment. Nine of
the recipients (47%) had obtained nonfederal extramural
research support before the year of initiating the K08 award
from other sources, including the American College of
Surgeons, the American Heart Association, the American
Surgical Association, the Association for Academic Surgery,
the Howard Hughes Foundation for Medical Research, the
Lifeline Foundation, the Pacific Vascular Research Foun-
dation, the Society of University Surgeons, and the Whi-
taker Foundation, as well as corporate and industry spon-
sors.
The research topics investigated by vascular surgeon
K08 recipients covered a broad spectrum of problems re-
lated to basic vascular biology and peripheral vascular dis-
ease (Table III). Primary research mentors included MD
(46%) and PhD (54%) scientists with principal appoint-
ments in basic science or clinical departments. All of these
research mentors were productive senior scientists with
independent NIH R01 funding, a solid track record of
research training experience, and a well-established rela-
tionship with the vascular surgeon K08 recipient.
Research productivity and transition to indepen-
dence. Between January 1999 and December 2005, vas-
cular surgeon K08 recipients contributed a cumulative total
of 460 peer-reviewed publications to the literature, includ-
ing 161 (35%) on laboratory research and 299 (65%) on
clinical topics (Table IV). During the award period, each
K08 recipient published a mean of 5.1  0.8 articles per
year (median, 5.5), including 1.9  0.3 per year on labo-
ratory research (median, 2.0) and 3.3  0.6 per year on
Table III. Research topics of vascular surgeon K08
recipients, 1999 to 2005
Topic Year
Genetic engineering of a failure resistant vein graft 1999
Control of endothelial translation by fluid shear stress 1999
Modulating endothelial adaptation to flow 1999
Inflammatory mechanisms of neointimal hyperplasia 2000
Nitric oxide and smooth muscle cell proliferation 2000
uPA receptor signaling and cell migration 2001
MMP-9-dependent vessel wall remodeling is
NO-dependent 2001
Bone morphogenetic proteins in arterial remodeling 2002
Thrombus resolution is CXC chemokine dependent 2002
Collagen-binding integrins in intimal hyperplasia 2002
The chemokine system in collateral artery formation 2002
Measuring the efficacy of endovascular treatment of AAA 2003
Collagen-IV remodeling in ischemic leg revascularization 2004
Mechanisms of shear-regulated vein graft remodeling 2004
Role of progenitor cells in hindlimb revascularization 2002
Homocysteine/hypertension and vascular lesion
formation 2004
mTOR regulation of VSMC differentiation 2004
Mitochondriopathy of chronically ischemic muscle 2005
A tissue-engineered, small-diameter vascular graft 2005
uPA, Urokinase-type plasminogen activator; MMP, matrix metalloprotein-
ase; NO, nitric oxide; mTOR, mammalian target of rapamycin; VSMC,
vascular smooth muscle cells.clinical topics (median, 3.5).
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assessed to include only those in which the vascular surgeon
K08 recipient was either the first or last author, the cumu-
lative total was 174 publications, including 67 (38%) on
laboratory research and 107 (62%) on clinical topics
(Table IV). The mean rate of first/last author publications
after receipt of the K08 award was 2.3  0.6 per recipient
per year distributed as 0.8  0.2 research publications and
1.6  0.5 clinical publications.
By December 2005, nine (47%) of the 19 vascular
surgeon K08 recipients had received promotion to associ-
ate professor of surgery with tenure during the period of
the award, including all seven of those holding the K08 for
at least 3 years. Five (26%) of the 19 recipients also held
joint faculty appointments in a basic science department or
graduate school.
As of June 2005, four recipients of the von Liebig K08
award and one recipient of an NHLBI K08 award had
completed the 5 years of mentored research training sup-
ported by the award. All five of these individuals subse-
quently achieved independent investigator status, with
three receiving NIH R01 research project grant support
and two serving as individual project leaders on NIH
program project grants. In addition, four other vascular
surgeon K08 recipients had submitted NIH R01 applica-
tions by December 2005, with one obtaining independent
funding and three others awaiting review and funding
decisions. As of December 2005, four of the vascular
surgeon K08 recipients had been invited to serve as mem-
bers of an NIH initial review panel (study section) or
research advisory committee.
DISCUSSION
Several interrelated factors have contributed to the
Table IV. Peer-reviewed publications by vascular surgeon
All Publications as Author/Co-Author
Year of Award 1999 2000 2001
Cum. number of recipients 3 5 7
Total publications 5 14 35
Research (% of total) 2 (40) 5 (36) 17 (49)
Clinical (% of total) 3 (60) 9 (64) 18 (51)
Publications per recipient 1.7 2.8 5.0
Research 0.7 1.0 2.4
Clinical 1.0 1.8 2.6
First/Last author publications during period of K08
award n
Total publications 1
Research publications, n (% of total) 67
Clinical publications, n (% of total) 107
Publications per recipient per year
Total
Research publications
Clinical publications
*Median
†Mean  standard error.decline in the number of surgeon investigators during thepast two decades (Table V). The working hypothesis in
developing the von Liebig K08 program was (1) that the
most vulnerable period for the academic vascular surgeon
occurs within the first 3 to 5 years of faculty appointment,
and (2) that adequate and realistic salary support during
this time would provide young vascular surgeon–scientists
the stimulus and means to launch effective, competitive,
and sustainable laboratory research programs. The Lifeline
Foundation and NHLBI leadership thereby constructed
the von Liebig K08 program to emphasize the importance
of structured research mentorship and to foster greater
familiarity with NIH peer-review and funding processes.
This structure also permitted applicants who were suffi-
recipients, 1999 to 2005
2002 2003 2004 2005 Total
11 13 17 19
61 83 138 124 460
22 (36) 22 (27) 46 (33) 47 (38) 161 (35)
39 (64) 61 (73) 92 (67) 77 (62) 299 (65)
5.5 6.4 8.1 6.5 5.5*
2.0 1.7 2.7 2.5 2.0*
3.5 4.7 5.4 4.1 3.5*
Mean†
2.3  0.6
0.8  0.2
1.6  0.5
Table V. Factors contributing to the decline in National
Institutes of Health funding for surgeon–scientists
1. Fewer applications submitted for NIH grants by surgeons
than other medical specialties
2. Applications submitted by surgeons less competitive than
those from other investigators
3. Limited representation of surgeons on NIH study sections,
panels, and councils
4. Deficiency and instability in the surgical research workforce
(quality and quantity)
a) Diminishing opportunity for surgical residents to engage
in research
b) Long discontinuities between initial research training
and faculty appointment
c) Competing clinical productivity demands during early
career development
d) Mid-career surgeons unable to commit sufficient effort
to sustain independent research
e) Few established surgical investigators remain in research
throughout their careersK08
(%)
74
(38)
(62)ciently competitive for NHLBI K08 awards to receive
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ted no more than two individuals each year to receive the
von Liebig K08 salary supplement.
The results presented here indicate that the von Liebig
K08 program has been a highly successful vehicle in stim-
ulating research career development in vascular surgery.
First, it is notable that beginning with the first year of the
program, a substantial number of K08 applications have
been submitted by vascular surgeons each year (range, 3
to 7). This indicates that under current training paradigms,
the pool of potential vascular surgeon–scientists—those
with adequate training, initial support, and interest in es-
tablishing research-based careers—has likely been suffi-
cient.24
Second, vascular surgeon K08 applicants were funded
at a slightly higher rate than the NHLBI average for K08
awards during the same time period (49% vs 41%), indicat-
ing that these applicants were equally competitive in this
arena with applicants from other medical specialties. This
counters the perception that vascular surgeons engaged in
laboratory-based research might not be sufficiently com-
petitive with their peers in other specialties and reinforces
the view that an increase in funded vascular surgeons could
be achieved if given an ample incentive to prepare and
submit applications for funding.
Third, vascular surgeon K08 recipients were highly
productive during the course of the award period, as indi-
cated by a steady rate of peer-reviewed publications and
research presentations, emerging national recognition,
procurement of additional research support, and academic
promotion. Even by relatively early measures these individ-
uals have already made important contributions to the field
of vascular surgery, and their ongoing involvement in re-
search-based activities is a hopeful sign for the next gener-
ation of academic leaders in the specialty.
Although still too early to draw firm conclusions, it
appears that by several measures the von Liebig K08 pro-
gram is already achieving its intended long-term impact.
Thus, all vascular surgeon K08 recipients who completed
the 5-year period of mentored research have emerged to
achieve independent investigator status, and several more
appear poised to follow. It is also notable that within their
respective institutions, each of these individuals has played
an important role in collaborative scientific programs and in
mentoring research experiences for medical students, sur-
gical residents, and vascular surgery fellows, thereby stim-
ulating further interest in vascular disease. The active par-
ticipation of vascular surgeon K08 recipients in other NIH
activities (study sections, advisory panels, and conferences)
is also apparent, and this level of broader involvement will
continue to be vital in sustaining the wider visibility and
influence of vascular surgeon-scientists. The von Liebig
K08 program has thereby proven to be a wise and fruitful
investment by the vascular surgery community.
The NIH K-series awards would appear to represent an
ideal funding mechanism to help meet the increasing chal-
lenge of research career development for clinician–scientists,
being specifically designated for clinically trained individu-als conducting mentored laboratory-based (K08) or pa-
tient-oriented (K23) research. Because the provisions of
the NIH K08/K23 awards require a research training
commitment of 75% of total professional effort, and be-
cause for many specialties the amount of salary provided is
less than half the Association of American Medical Colleges
median salary for individuals holding an appointment at the
assistant professor level, there remains a significant fiscal
discrepancy that may discourage investigators from seeking
this means of support. The salary supplement provided by
the von Liebig K08 award was designed to offset this
discrepancy, thereby allowing the recipient to commit the
required 75% effort to research career development while
maintaining a reasonable measure of clinical activity. It is
notable that this amount of clinical activity is considered a
crucial provision for technically-demanding and rapidly-
evolving specialties such as vascular surgery, in which junior
faculty members must maintain and extend clinical capabil-
ities acquired during training, establish credibility as at-
tending physicians and surgeons, and adopt new technical
skills with emerging endovascular procedures, all alongside
the development of research expertise.
CONCLUSION
The von Liebig K08 program serves as one example of
a successful partnership between private and public sectors
to meet the ongoing challenges of research career develop-
ment. This paradigm has recently been emulated to develop
a similar K23 program for patient-oriented research in
vascular surgery, and by salary-matching K08/K23 pro-
grams offered by other clinical specialties, such as cardio-
thoracic surgery and trauma surgery. Other potential solu-
tions to stimulating research career development should
also be considered and pursued, particularly to offset the
disproportionate amounts of clinical activity between dif-
ferent medical and surgical specialties.25 For example, it
might be feasible (and cost-neutral) to consider reducing
the 75% effort requirement for K-series awards, perhaps to
50%, at least for certain clinically intense specialties. An-
other reasonable strategy would be to allow the propor-
tionate percent effort for K-series awards to be calculated
on the basis of a 40-hour workweek, rather than the percent
of “total professional activity” as calculated at present. For
an academic surgeon with professional demands that oth-
erwise typically encompass 80 hours per week, this ap-
proach would permit a commitment of 30 hours per week
to the K08/K23 program yet allow a considerable amount
of remaining time for clinical practice and other profes-
sional activity. This approach also has the advantage that it
would be equitable for all clinicians, regardless of specialty,
thereby helping to restore equilibrium to a funding system
that currently disfavors individuals in clinically demanding
specialties.
We are grateful to Ms Sarah Murphy (American Vascu-
lar Association, Chicago, IL) for assistance in preparing this
report and to the vascular surgeon K08 recipients for
providing essential data.
JOURNAL OF VASCULAR SURGERY
Volume 45, Number A Thompson et al 7AREFERENCES
1. Yao JST. Research and research funding in vascular surgery. J Vasc Surg
1990;12:84-90.
2. Stanley JC. Vascular fellowships and laboratory research. J Vasc Surg
1991;13:551-4.
3. Greisler HP. The hour is getting late. J Vasc Surg 1998;27:795-804.
4. Abbott WM. Legend, leadership, legacy. J Vasc Surg 1999;29:1-7.
5. Yao JST, Mannick J. Lifeline Foundation and National Institutes of
Health. J Vasc Surg 2001;33:1237-8.
6. Galt SW, Kraiss LW, Sarfati MR. Has the changing nature of vascular
surgery adversely affected scholarly activity? J Vasc Surg 2003;38:1-6.
7. Graham LM. Surgical research: facing new realities. Surgery 1995;118:
123-9.
8. Souba WW, Tanabe KK, Gadd MA, Smith BL, Bushman MS. Attitudes
and opinions toward surgical research: a survey of surgical residents and
their chairpersons. Ann Surg 1996;223:377-83.
9. Dunn JC, Lai EC, Brooks CM, Stabile BE, Fonkalsrud EW. The
outcome of research training during surgical residency. J Pediatr Surg
1998;33:362-4.
10. Ko CY, Whang EE, Longmire WP Jr, McFadden DW. Improving the
surgeon’s participation in research: is it a problem of training or priority?
J Surg Res 2000;91:5-8.
11. Jones RS, Debas HT. Research: a vital component of optimal patient
care in the United States. Ann Surg 2004;240:573-7.
12. Wyngaarden JB. The clinical investigator as an endangered species.
N Engl J Med 1979;301:1254-9.
13. Cadman EC. The academic physician-investigator: a crisis not to be
ignored. Ann Intern Med 1994;120:401-10.
14. Goldstein JL, Brown MS. The clinical investigator: bewitched, both-
ered, and bewildered- but still beloved. J Clin Invest 1997;99:2803-12.15. Schrier RW. Ensuring the survival of the clinician-scientist. Acad Med
1997;72:589-94.
16. Rosenberg LE. The physician-scientist: an essential and fragile link in
the medical research chain. J Clin Invest 1999;103:1621-6.
17. Zemlo TR, Garrison HH, Partridge NC, Ley TJ. The physician-scien-
tist: career issues and challenges at the year 2000. FASEB J 2000;14:
221-30.
18. Lenfant C. Training the next generation of biomedical researchers:
challenges and opportunities. Circulation 2000;102:368-71.
19. Rangel SJ, Efron B, Moss L. Recent trends in National Institutes of
Health funding of surgical research. Ann Surg 2002;236:277-87.
20. Rangel SJ, Moss RL. Recent trends in the funding and utilization of
NIH career development awards by surgical faculty. Surgery 2004;136:
232-9.
21. Jackson HH, Jackson JD, Mulvihill SJ, Firpo MA, Glasgow RE. Trends
in research support and productivity in the changing environment of
academic surgery. J Surg Res 2004;116:197-201.
22. Debas HT, Bass BL, Brennan MF, Flynn TC, Folse JR, Freischlag JA ,
et al. American Surgical Association blue ribbon committee report on
surgical education: 2004. Ann Surg 2005;241:1-8.
23. Ley TJ, Rosenberg LE. The physician-scientist career pipeline in 2005:
build it, and they will come. JAMA 2005;294:1343-51.
24. Henke PK, Kish P, Stanley JC. Relevance of basic laboratory and clinical
research activities as part of the vascular surgery fellowship: an assess-
ment by program directors and postfellowship surgeons. J Vasc Surg
2002;36:1083-91.
25. Zelenock GB, Stanley JC, More RA, Greenfield LJ, Shanley CJ, Jacobs
LA. Differential clinical workloads among faculty at a major academic
health center. Ann Surg 1997;226:336-45.Submitted Jan 18, 2007; accepted Feb 16, 2007.
